Investing Ideas
/
Australian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Australian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses

52 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
VLS Vita Life Sciences	AU$1.95	2.4%	3.5%	AU$111.9m	n/a	PE11.6x	n/a	4.6%
EZZ EZZ Life Science Holdings	AU$3.03	-2.3%	384.8%	AU$137.6m	AU$5.45	PE20.1x	E17.9%	1.0%
ACR Acrux	AU$0.032	-3.0%	-37.3%	AU$9.6m	AU$0.11	PS1.8x	E91.8%	0%
BDX BCAL Diagnostics	AU$0.099	8.8%	0%	AU$34.8m	AU$0.20	PS11.5x	E90.6%	n/a
PER Percheron Therapeutics	AU$0.009	12.5%	-84.2%	AU$8.5m	AU$0.09	PS3.2x	E24.7%	n/a
MVP Medical Developments International	AU$0.42	6.3%	-54.5%	AU$47.3m	AU$2.94	PS1.4x	E93.1%	0%
BOT Botanix Pharmaceuticals	AU$0.45	7.1%	136.8%	AU$817.9m	AU$0.65	PS395.2x	E99.4%	n/a
ARX Aroa Biosurgery	AU$0.74	-3.2%	-5.7%	AU$257.0m	AU$0.95	PS3.7x	E59.7%	n/a
ECS ECS Botanics Holdings	AU$0.017	0%	-24.4%	AU$21.9m	n/a	PE11.4x	n/a	n/a
GSS Genetic Signatures	AU$0.66	4.8%	56.0%	AU$149.9m	AU$1.10	PS10.8x	E98.6%	n/a
MSB Mesoblast	AU$3.17	12.0%	974.6%	AU$3.8b	AU$1.86	PS380.2x	E53.7%	n/a
CYP Cynata Therapeutics	AU$0.23	10.7%	86.0%	AU$43.4m	AU$0.83	PS18.1x	E72.9%	n/a
NSB NeuroScientific Biopharmaceuticals	AU$0.033	0%	-15.4%	AU$4.8m	n/a	PE14.7x	n/a	n/a
IMC Immuron	AU$0.077	-2.5%	-2.5%	AU$17.9m	AU$0.29	PS3.6x	E22.4%	n/a
ACW Actinogen Medical	AU$0.027	12.5%	22.7%	AU$79.9m	n/a	PS8.4x	E-22.1%	n/a
MYX Mayne Pharma Group	AU$4.64	-2.9%	-20.0%	AU$389.5m	AU$6.10	PS1x	E111.4%	n/a
ATH Alterity Therapeutics	AU$0.01	42.9%	100.0%	AU$47.9m	AU$0.036	PS13.2x	E-19.2%	n/a
PIQ Proteomics International Laboratories	AU$0.80	31.4%	-6.5%	AU$102.8m	AU$0.50	PS31.8x	E28.8%	n/a
CHM Chimeric Therapeutics	AU$0.0075	25.0%	-79.2%	AU$7.0m	n/a	PS1x	n/a	n/a
EX1 Exopharm	AU$0.011	0%	-81.7%	AU$4.8m	n/a	PS1.4x	n/a	n/a
PAB Patrys	AU$0.003	-25.0%	-62.5%	AU$8.2m	n/a	PS4.4x	n/a	n/a
RAC Race Oncology	AU$1.40	2.6%	67.1%	AU$238.0m	AU$6.37	PS60.5x	E0.1%	n/a
ATX Amplia Therapeutics	AU$0.093	8.1%	14.8%	AU$30.8m	AU$0.24	PS9.4x	n/a	n/a
PAR Paradigm Biopharmaceuticals	AU$0.41	5.1%	-9.9%	AU$139.8m	AU$0.85	PB6x	E-13.2%	n/a

Page 1 of 3